Common Diabetes Drug Shows Promise as Treatment for COVID-19 Lung Inflammation
The blood sugar-lowering drug metformin prevented pulmonary inflammation, a major factor in COVID-19 severity and mortality, in studies of mice infected by the SARS-CoV-2 coronavirus